Octagon Capital Advisors LP / RAPT
Octagon Capital Advisors LP’s Rapt Therapeutics Inc Position
Does Octagon Capital Advisors LP own Rapt Therapeutics Inc (RAPT)? Not currently — the last reported position was 574.0K shares worth $19M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$19M
Q4 2025
Shares
574.0K
% of Portfolio
+2.36%
Quarters Held
1
position exited
Position History RAPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 574.0K | $19M | +2.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of RAPT.